Compare SST & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SST | BNGO |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | United States | United States |
| Employees | 250 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 11.6M |
| IPO Year | N/A | 2018 |
| Metric | SST | BNGO |
|---|---|---|
| Price | $3.69 | $1.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $10.00 | $7.50 |
| AVG Volume (30 Days) | ★ 6.3M | 275.4K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000,735.00 |
| Revenue This Year | N/A | $16.19 |
| Revenue Next Year | N/A | $33.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.29 | $1.06 |
| 52 Week High | $11.30 | $5.50 |
| Indicator | SST | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 47.66 |
| Support Level | $3.55 | $1.08 |
| Resistance Level | $4.54 | $1.18 |
| Average True Range (ATR) | 1.00 | 0.08 |
| MACD | 0.29 | 0.00 |
| Stochastic Oscillator | 56.18 | 16.22 |
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.